Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Class I phosphoinositide 3-kinases.

Karen E Anderson1, Shaun P Jackson

  • 1Department of Medicine, Australian Centre for Blood Diseases, Monash University, Box Hill Hospital, Victoria 3128, Australia. Karen.Anderson@med.monash.edu.au

The International Journal of Biochemistry & Cell Biology
|April 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vasopressin 1a Receptor Antagonists for Pathological Aggression in Neurodegenerative and Other CNS Diseases.

Biomedicines·2026
Same author

Engineering ultrapotent trivalent anticoagulants through hybridisation of salivary peptides from multiple haematophagous organisms.

Chemical science·2025
Same author

Oncometabolite 5-IP<sub>7</sub> inhibits inositol 5-phosphatase to license E-cadherin endocytosis.

Nature chemical biology·2025
Same author

SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.

The Journal of clinical investigation·2025
Same author

FGF-induced phospholipase Cγ signaling regulates lacrimal gland branching by competing with PI3K in phosphoinositide metabolism.

Cell reports·2025
Same author

Ischaemic endothelial necroptosis induces haemolysis and COVID-19 angiopathy.

Nature·2025
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Phosphoinositide 3-kinases (PI3-kinases) are enzymes crucial for cell signaling. Understanding their distinct roles and differential regulation is key to developing targeted therapies for diseases like cancer and inflammatory conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Phosphoinositide 3-kinases (PI3-kinases) are enzymes catalyzing the 3'-phosphorylation of phosphoinositides.
  • PI3-kinases are classified into three main classes (I, II, III) based on structural and functional characteristics.
  • Emerging evidence highlights differential regulation and distinct cellular roles for various PI3-kinase isoforms.

Purpose of the Study:

  • To elucidate the diverse functions and regulatory mechanisms of PI3-kinase isoforms.
  • To explore the involvement of PI3-kinases in cellular responses and human disease pathogenesis.
  • To assess the therapeutic potential of targeting specific PI3-kinase isoforms.

Main Methods:

  • Enzyme assays to determine substrate specificity.

Related Experiment Videos

  • Biochemical analyses of protein structure and homology.
  • Cellular studies investigating signaling pathways.
  • Literature review of PI3-kinase involvement in disease.

    • Main Results:

    • PI3-kinase isoforms exhibit distinct substrate specificities and regulatory patterns.
    • PI3-kinase activity is implicated in numerous cellular processes.
    • Dysregulation of PI3-kinases is linked to the pathogenesis of various human diseases.

    Conclusions:

    • PI3-kinase isoforms play critical, distinct roles in cellular function.
    • Targeted inhibition of specific PI3-kinase isoforms holds promise for treating cancer, inflammatory, and immunological diseases.
    • Further research into PI3-kinase isoform-specific inhibitors is warranted for therapeutic development.